Immune checkpoint inhibitor-associated myocarditis and pericarditis: a pharmacovigilance study based on the FAERS database

Abstract Background Immune checkpoint inhibitors (ICIs) are medications used in cancer immunotherapy. However, treatment with ICIs may lead to adverse effects, particularly myocarditis and pericarditis. This practical pharmacovigilance study investigates the relationship between ICIs and myocarditis...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Guojing Yao, Yu Zhang, Haixia Zhang, Linlin Tang, Chuanhua Ding, Xueheng Zhou
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2025-08-01
coleção:	BMC Cancer
Assuntos:	Immune checkpoint inhibitors (ICIs) Myocarditis/pericarditis Pharmacovigilance FDA adverse event reporting system (FAERS) Data mining
Acesso em linha:	https://doi.org/10.1186/s12885-025-14668-x
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!